A02057  SARS-CoV-2 Neutralizing Antibody (BS-M0220), mAb, Mouse产品图

A02057 SARS-CoV-2 Neutralizin

g Antibody (BS-M0220), mAb, Mouse
收藏
  • ¥2800
  • GenScript
  • A02057
  • 2026年06月30日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      100μg

    产品概述
    Specificity The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
    Host Species Mouse
    Immunogen Recombinant SARS-CoV-2 Spike protein fragment
    Conjugate Unconjugated


    应用指导
    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    ELISA 0.01-0.1 µg/ml
    Surrogate Virus Neutralization Test (sVNT) 0.2-1 µg/ml


    产品属性
    Form Liquid
    Storage Buffer 0.2 μm filtered solution in PBS, pH 7.4.
    Concentration 1 mg/ml
    Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Mouse IgG2a
    Clonality Monoclonal
    Clone ID BS-M0220
    Note GenScript can customize this product per customer's request including product size, buffer components, etc.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Neutralizing Bioassay Protocols

      describe in vitro bioassays using neutralizing anti-mouse and anti-human cytokine antibodies. In general, the cytokine bioassay protocols are modified to pre-incubate the cytokine of interest with the specific neutralizing antibody prior to addition

    • The production of monoclonal antibody by hybridoma

      , A., Popkov, M., Cortez, X., Fuller, R., Elia, M., Kerwin, L., and C.F. Barbas III. (2003) Rapid monoclonal antibody generation via dendritic cell targeting in vivo. Hybridoma and Hybridomics 22 (1), 23-31.  

    • 信号传导

      of interest with the specific neutralizing antibody prior to addition to the responding cells.     FAQs for Signal Transduction (LTI) Lots of useful information on signal transduction  

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2800
    广州市左克生物科技发展有限公司
    2026年06月30日询价
    询价
    北京柏瑞图科技有限公司
    2026年02月19日询价
    询价
    上海北诺生物科技有限公司
    2025年06月07日询价
    ¥3200
    北京博奥森生物技术有限公司
    2025年10月15日询价
    ¥5040
    西宝生物科技(上海)股份有限公司
    2026年06月04日询价
    A02057 SARS-CoV-2 Neutralizing Antibody (BS-M0220), mAb, Mouse
    ¥2800